Background: Fractured neck of femur (NOF) is a leading cause of morbidity and mortality in the elderly. Published clinical guidelines suggest early adequate analgesia as a key management aim. The femoral nerve '3-in-1 block' has previously been shown to provide effective analgesia for these patients in the peri-and post-operative phase of care. The aim of this study was to examine the use of the '3-in-1' femoral nerve block as primary analgesia for patients with a fractured NOF presenting to the emergency department. Methods: This was a single centre pragmatic randomised controlled open-label trial comparing femoral nerve block (using a '3-in-1' technique) with intravenous (IV) morphine. A convenience sample of patients presenting to the emergency department of a district general hospital with a clinically or radiologically suspected fractured NOF were recruited. They were randomised to receive either 0.1 mg/kg IV bolus of morphine or a '3-in-1' femoral nerve block with 30 ml of 0.5% plain bupivacaine. Visual analogue pain scores were noted prior to treatment and at 30 minutes, 2 hours, 6 hours and 12 hours after treatment. Immediate complications such as vascular puncture or the requirement for naloxone were noted. Results: Forty patients were recruited, 22 patients were randomised to IV morphine and 18 patients were randomised to '3-in-1' femoral nerve block. Complete data were available for 33 patients. There was no significant difference in initial median pain score (p=0.45). Analysis using the Wilcoxon test showed a significant decrease in pain score for the morphine group (p=0.01) and the nerve block group (p<0.01) at 30 minutes compared with baseline. Analysis using the Mann-Whitney U test between median pain scores at each time point showed a significant lower pain score in the nerve block group at 30 minutes (p=0.046). There were no immediate complications in either group. Conclusion: Our results suggest that a '3-in-1' femoral nerve Correspondence* to:
block is at least as effective as IV morphine when used as primary analgesia for patients with fractured NOF. Our results suggest that the femoral nerve block may provide better analgesia at 30 minutes. 
Introduction
Fractured neck of femur (NOF) is a significant cause of morbidity and mortality among the elderly. [1] [2] [3] The vast majority of these patients will present to the emergency department (ED). Early adequate analgesia is a key management aim and this has been highlighted in United Kingdom guidelines by the Scottish Intercollegiate Guideline Network (SIGN) 4 and the Royal College of Physicians. 5 Femoral nerve blocks, using the '3-in-1' technique originally described by Winnie (Appendix 1), 6 have been shown to provide effective analgesia for these patients in the peri-operative period and to reduce other analgesic requirements. [7] [8] [9] Regional anaesthesia has several theoretical benefits over parenteral analgesia including reduced respiratory depression and reduced confusion.
A Cochrane review (comparing regional and general anaesthesia for fractured neck of femur) supported this and showed a reduction in 30 day mortality, but not in long term outcome, when regional anaesthetic techniques were used for hip fracture surgery. 10 A further Cochrane review of the use of nerve blocks in the pre-and peri-operative phases showed that requirements for opiates were reduced but found no evidence to confirm any reduction in the incidence of complications relating to parenteral analgesia. 11 The aim of this study was to examine the use of the '3-in-1' femoral nerve block as primary analgesia for patients with a fractured NOF presenting to the ED.
Methods

Design
This was a single centre pragmatic randomised controlled open-label trial comparing femoral nerve block using a '3-in-1' technique with intravenous (IV) morphine. This was conducted in the ED of a district general hospital. Patients over the age of 16 presenting with clinical or radiological evidence of fractured hip were eligible for inclusion. Informed written consent was obtained after clinical assessment including the abbreviated mental test (AMT). 12 Patients were excluded if they had a known allergy or contraindication to either morphine or bupivacaine or if they had an AMT score of less than nine.
Patients were then randomised using numbered, sequential, sealed opaque envelopes to receive either standard analgesia with IV opiate or a '3-in-1' femoral nerve block of the fractured hip. The Local Research Ethics Committee approved the study. Patients randomised to the nerve block group received a '3-in-1' femoral nerve block with 30 ml of 0.5% bupivacaine, not exceeding 3 mg/kg. Patient weights were estimated in view of the logistical challenges of obtaining a more accurate weight in this patient group in the ED. All staff received a standardised tutorial and written instructions from the principal investigator (ACMcG) describing the technique and potential complications. Ner ve blocks were performed principally using anatomical landmarks as previously described by Winnie (Appendix 1), and a nerve stimulator was used to help with nerve localisation.
Outcomes
The primary outcome measure was pain scores, as measured using visual analogue scores. Visual analogue pain scores were recorded prior to treatment and at 30 minutes, 2 hours, 6 hours and 12 hours after intervention. Secondary outcome measures were immediate complications, use of further intravenous opiates in the first 24 hours and significant preoperative events. Patients in both groups were prescribed a standard analgesic protocol for in-patient use over the first 24 hours (Appendix 2).
I m m e d i a t e c o m p l i c a t i o n s w e r e d e f i n e d a s inadvertent vascular puncture, anaphylaxis or collapse, severe pain or inability to tolerate the p r o c e d u re . Wi t h i n t h e m o r p h i n e g ro u p t h e i m m e d i a t e c o m p l i c a t i o n s w e r e d e f i n e d a s anaphylaxis or collapse, respiratory depression or the requirement for naloxone use within one hour of IV morphine administration. Total use of morphine over the first 24 hours or to induction of anaesthesia prior to surgery, whichever was sooner, was noted in both groups. Significant preoperative events, such as confusion, were recorded.
Data was analysed using the Minitab statistical package. Visual analogue pain scores were analysed using standard non-parametric statistical tests, including the Wilcoxon and Mann-Whitney U tests.
Results
A total of 40 patients were recruited between April 2000 and October 2001 and randomised as shown in Figure 1 , 22 patients were randomised to receive IV morphine and 18 patients were randomised to receive a '3-in-1' femoral nerve block. No patients were estimated to weigh less than 50 kg, so standard volumes (30 ml) of 0.5% bupivacaine were used for all patients randomised to that group.
One patient in the morphine group was unable to complete the study due to development of an acute confusional state. Full data was unavailable for a further three patients in the IV morphine group due to incomplete data collection post intervention. Within the '3-in-1' nerve block group, one patient was found to have an impalpable femoral artery on the side of the hip fracture after randomisation and was unable to receive a nerve block due to lack of anatomical landmarks. Full data was unavailable for a further two patients due to incomplete data collection post intervention. Full results were available for 33 patients, 18 in the morphine group and 15 in the femoral nerve block group.
Analysis of patient characteristics showed no significant differences between the intervention group and the control group. Mean age was 81 years in the morphine group versus 77 years in the femoral nerve block group (p=0.08). There was no gender difference, with 94% females in the morphine group versus 93% females in the femoral nerve block group (p=0.89). All patients had an AMT score of 9 or 10 prior to randomisation. All patients who were entered into the trial on the basis of clinical evidence of a hip fracture had this positively confirmed by radiological assessment.
There was no significant difference in pre-intervention median visual analogue pain scores between the two groups (p=0.45). Analysis using the Wilcoxon test showed a significant drop in pain scores for the morphine group (p=0.01) and nerve block group (p<0.01) at 30 minutes compared with baseline.
Analysis using the Mann-Whitney U test between median pain scores at each time point showed a significantly lower median pain score at 30 minutes in the nerve block group compared with the morphine group (p=0.046). Median pain scores for each time interval are demonstrated in Figure 2 . There were no statistical differences between the median pain scores of the two groups at any other time.
There were no immediate complications in either group. The peripheral nerve stimulator and nerve block technique were tolerated by all of the patients in the nerve block group. The average time to complete the nerve block was 5-10 minutes, whereas the IV morphine injection took around 2-3 minutes (both times not including the time for IV cannulation).
The total number of morphine boluses given in the first 24 hours (both in the ED and ward) subsequent to the initial analgesic method was recorded. This showed no significant difference between the morphine group (mean 1.7 doses) and the femoral nerve block group (mean 1.5 doses, p=0.58). There was no statistical difference in acute confusion between the groups, with no patient developing confusion in the femoral nerve block and one patient developing confusion in the IV morphine group (p=0.35).
Discussion
With an increasing elderly population, fractured neck of femur is a growing problem. An estimated 1.7 million hip fractures occurred world-wide in 1990. 13 Currently approximately 57,000 patients per year suffer a fractured neck of femur in England and Wales.
14 This number will Figure 1 . Breakdown of patient disposition following randomisation.
increase as the population ages but also as age-standardised rates of hip fractures continue to increase. 15 These patients present a significant challenge to ED staff in terms of initial pain management, particularly during the initial assessment period in which they may be moved for imaging or transfer to a ward. These patients often have co-existent cardiorespiratory disease 16 and may not tolerate clinically effective doses of opiate. Morbidity and mortality from fractured neck of femur is significant, with 20-35% mortality at 6 months. 17 Regional anaesthesia at the time of surgery has been shown to reduce short-term mortality in patients with hip fracture. 7 This study suggests that the '3-in-1' femoral nerve block is an effective and practical way to provide initial analgesia for patients with fractured neck of femur. A '3-in-1' femoral nerve block given in the ED provides effective analgesia for patients with fractured neck of femur and may provide better analgesia at 30 minutes compared with standard doses of IV morphine. Although the nerve block may take slightly longer to perform, the perceived advantages of the nerve block (improved analgesia, less respiratory depression, reduced confusion) may outweigh the longer time taken to perform the block.
Several larger trials have also shown that '3-in-1' femoral nerve blocks are safe with few adverse events. 18, 19 Our study concurs with this finding, as senior ED medical staff were able to provide a '3-in-1' femoral nerve block after basic training with no procedure related adverse events. In particular, there were no adverse effects associated with the use of the nerve stimulator in these patients.
Limitations of our study include the low numbers of patients and the unavoidable loss of data in several patients who were recruited to the study and randomised. It is possible that the dose of IV morphine was too low, but 0.1 mg/kg is a standard initial dose recommendation in major textbooks of emergency medicine and it is the standard for comparison of other analgesic techniques in the emergency department. It is also possible that body weights were not accurately measured, but given the randomised nature of the study, this inaccuracy should have been of the same order of magnitude for each arm of the study and therefore should have little systematic bearing on the outcome. It is possible that the use of a regional anaesthesia technique may lead to fewer problems with respiratory depression, hypotension and mental obtundation in the elderly, but due to the small numbers in our study, we were unable to show significant differences in these complications. Further larger, funded studies should explore the potential for use of the '3-in-1' femoral nerve block in the ED, with an emphasis on the efficacy and tolerability of nerve stimulators after femoral fracture, and the effect, if any, on 30 day mortality.
Conclusion
Our results show that the '3-in-1' femoral nerve block is at least as effective as IV morphine when used for primary analgesia of patients presenting to the ED with a fractured NOF. Larger randomised controlled trials are required to confirm this in different ED populations and to examine the relative complication rates of both nerve block and intravenous morphine.
